236 related articles for article (PubMed ID: 10139729)
21. Drug information services at Burroughs Wellcome Co.
Collins GE
Am J Hosp Pharm; 1990 Sep; 47(9):1991-3. PubMed ID: 2220848
[No Abstract] [Full Text] [Related]
22. Getting SMART (submission management and review tracking) drug review in the computer age.
Flieger K
FDA Consum; 1995 Oct; 29(8):6-9. PubMed ID: 10151839
[TBL] [Abstract][Full Text] [Related]
23. Bristol-Myers cleans up its mess.
Revell J
Fortune; 2003 Feb; 147(3):136-8. PubMed ID: 12608105
[No Abstract] [Full Text] [Related]
24. Bristol-Myers Squibb pushes BuSpar compliance.
Telemed Virtual Real; 1998 Dec; 3(12):144. PubMed ID: 10345193
[No Abstract] [Full Text] [Related]
25. Outcomes research: collaboration among academic researchers, managed care organizations, and pharmaceutical manufacturers.
Kong SX; Wertheimer AI
Am J Manag Care; 1998 Jan; 4(1):28-34. PubMed ID: 10179904
[TBL] [Abstract][Full Text] [Related]
26. An audience with...Joseph Bolen. Interview by Bethan Hughes.
Bolen J
Nat Rev Drug Discov; 2009 Aug; 8(8):608. PubMed ID: 19644470
[TBL] [Abstract][Full Text] [Related]
27. [Marketing of pediatric drugs].
Pabst JY
Soins Pediatr Pueric; 2003; (210):18-9. PubMed ID: 12683130
[No Abstract] [Full Text] [Related]
28. Deal watch: Bristol-Myers Squibb and Exelixis collaborate on kinase inhibitors.
Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180098
[No Abstract] [Full Text] [Related]
29. Directory of pharmacist-operated drug information centers in the United States.
Rosenberg JM; Kirschenbaum HL; Labella NA
Am J Hosp Pharm; 1982 Jan; 39(1):94-8. PubMed ID: 7034535
[TBL] [Abstract][Full Text] [Related]
30. Is drug advertising informing the consumer?
Hanlon PM
Behav Healthc Tomorrow; 2002 Feb; 11(1):SR35-7. PubMed ID: 11837141
[No Abstract] [Full Text] [Related]
31. The pharmaceutical industry as an informant.
Collier J; Iheanacho I
Lancet; 2002 Nov; 360(9343):1405-9. PubMed ID: 12424005
[TBL] [Abstract][Full Text] [Related]
32. The patient information and education initiative.
Rheinstein PH; McGinnis TJ; Nightingale SL
Am Fam Physician; 1995 Dec; 52(8):2377-8, 2381-2. PubMed ID: 7484726
[No Abstract] [Full Text] [Related]
33. Case study: impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998-2006.
Houston JG; Banks MN; Binnie A; Brenner S; O'Connell J; Petrillo EW
Drug Discov Today; 2008 Jan; 13(1-2):44-51. PubMed ID: 18190863
[TBL] [Abstract][Full Text] [Related]
34. Disease management strategy: initiative links pharmaceutical and mental health data.
Docherty JP
Behav Healthc Tomorrow; 1996 Feb; 5(1):51-3. PubMed ID: 10158450
[TBL] [Abstract][Full Text] [Related]
35. Nursing home consultant pharmacists: drug information services, opinions, and activity study.
Evens RP; Guernsey BG; Hightower WL
Hosp Formul; 1982 Mar; 17(3):408-11, 418-20. PubMed ID: 10254880
[No Abstract] [Full Text] [Related]
36. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
37. Information responsibilities of generic drug companies.
Cramer R
Am J Hosp Pharm; 1986 Jul; 43(7):1674, 1679. PubMed ID: 3752098
[No Abstract] [Full Text] [Related]
38. Quality of drug information service provided by pharmaceutical manufacturers.
Doyal LE
Am J Hosp Pharm; 1990 May; 47(5):1014. PubMed ID: 2337090
[No Abstract] [Full Text] [Related]
39. Bristol-Myers Squibb to pay $0.5bn to settle US lawsuits.
Tanne JH
BMJ; 2007 Oct; 335(7623):742-3. PubMed ID: 17932180
[No Abstract] [Full Text] [Related]
40. Pharmacists' role in facilitating evidence-based prescribing for unlabeled use of medications.
Macaulay TE; Cook AM; Fink JL; Rapp RP; Vincent WR
Am J Health Syst Pharm; 2009 Oct; 66(19):1735-9. PubMed ID: 19767380
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
